Zoetis Holds Annual Meeting of Shareholders
May 01 2015 - 1:19PM
Business Wire
Speaking to shareholders at the Zoetis Inc. (NYSE:ZTS) annual
meeting today in Short Hills, N.J., Chief Executive Officer Juan
Ramón Alaix highlighted the company’s 2014 performance and
strategies for future growth as the global market leader in animal
health.
Zoetis CEO Juan Ramon Alaix speaking at
the 2015 Annual Meeting of Shareholders.
“In our second year as a public company, we generated strong
profitable growth, built on the core strengths of our business
model and continued to create value for our customers and
shareholders,” said Alaix. “This year, we will continue to enhance
and protect our competitive advantages, improve our working capital
efficiency, achieve margin improvements and return excess capital
to shareholders.”
Zoetis Chairman Michael McCallister presided over the business
portion of the meeting and shareholder voting. Preliminary results
of shareholder voting from the meeting are as follows:
- Sanjay Khosla, Dr. Willie M. Reed and
William C. Steere, Jr. have been elected as directors for
three-year terms.
- Shareholders voted to approve the
compensation of the company’s named executive officers.
- Shareholders ratified and approved
the selection of KPMG LLP as the company’s independent registered
public accounting firm for the 2015 fiscal year.
The final results of the shareholder voting are subject to
verification by the independent election inspectors; results will
be filed in a Form 8-K and available on the Investor section of the
Zoetis website.
A full replay of the meeting will be made available at
http://investor.zoetis.com/events-presentations, along with the
presentation materials from the event.
About Zoetis
Zoetis (zô-EH-tis) is the leading animal health company,
dedicated to supporting its customers and their businesses.
Building on more than 60 years of experience in animal health,
Zoetis discovers, develops, manufactures and markets veterinary
vaccines and medicines, complemented by diagnostic products and
genetic tests and supported by a range of services. In 2014, the
company generated annual revenue of $4.8 billion. With
approximately 10,000 employees worldwide at the beginning of 2015,
Zoetis has a local presence in approximately 70 countries,
including 27 manufacturing facilities in 10 countries. Its products
serve veterinarians, livestock producers and people who raise and
care for farm and companion animals in 120 countries. For
more information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This
press release contains forward-looking statements, which reflect
the current views of Zoetis with respect to business plans or
prospects, future operating or financial performance, expectations
regarding products, future use of cash and dividend payments, and
other future events. These statements are not guarantees of future
performance or actions. Forward-looking statements are subject to
risks and uncertainties. If one or more of these risks or
uncertainties materialize, or if management's underlying
assumptions prove to be incorrect, actual results may differ
materially from those contemplated by a forward-looking statement.
Forward-looking statements speak only as of the date on which they
are made. Zoetis expressly disclaims any obligation to update or
revise any forward-looking statement, whether as a result of new
information, future events or otherwise. A further list and
description of risks, uncertainties and other matters can be found
in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2014, including in the sections thereof captioned
“Forward-Looking Information and Factors That May Affect Future
Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on
Form 10-Q and in our Current Reports on Form 8-K. These filings and
subsequent filings are available online at www.sec.gov,
www.zoetis.com, or on request from Zoetis.
Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20150501005728/en/
Zoetis Inc.Media:Bill Price,
973-443-2742william.price@zoetis.comorKristen Seely,
973-443-2777kristen.seely@zoetis.comorInvestors:John
O'Connor, 973-822-7088john.oconnor@zoetis.comorSteve Frank,
973-822-7141steve.frank@zoetis.com
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Zoetis (NYSE:ZTS)
Historical Stock Chart
From Jul 2023 to Jul 2024